Price target upside
Spyre Therapeutics Price Target: +38.4% vs Current Price
SYRE target gap is +38.4% from $86.47 to $119.71. As of 2026-09-02.
Direct answer
Spyre Therapeutics's analyst target implies +38.4%.
The average target is $119.71 compared with a recorded current price of $86.47.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked September 2, 2026.
Get free Spyre Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $86.47
- Average price target
- $119.71
- High price target
- $130.00
- Low price target
- $97.00
- Low target gap
- +12.2%
- Target upside
- +38.4%
- High target gap
- +50.3%
- Target range width
- 38.2%
- Consensus rating
- Strong Buy
- Analysts
- 14
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Spyre Therapeutics's average target imply?
Spyre Therapeutics's average target is $119.71 versus a recorded price of $86.47. The difference is +38.4%.
How far are Spyre Therapeutics's low and high targets from the recorded price?
The low target implies +12.2%, while the high target implies +50.3%.
How many analysts are included in Spyre Therapeutics's consensus?
The verified consensus includes 14 analysts.
How is Spyre Therapeutics's target upside or downside calculated?
The average target of $119.71 is divided by the recorded price of $86.47, then one is subtracted to produce +38.4%. This does not guarantee a future return.
When was Spyre Therapeutics's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.